Tower Research Capital (TRC)’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-8,703
Closed -$130K 6795
2022
Q4
$130K Buy
8,703
+5,964
+218% +$89.1K 0.01% 1625
2022
Q3
$23K Buy
2,739
+2,106
+333% +$17.7K ﹤0.01% 3843
2022
Q2
$4K Sell
633
-813
-56% -$5.14K ﹤0.01% 5337
2022
Q1
$8K Sell
1,446
-12,049
-89% -$66.7K ﹤0.01% 4668
2021
Q4
$63K Buy
13,495
+10,360
+330% +$48.4K ﹤0.01% 2591
2021
Q3
$20K Sell
3,135
-25,629
-89% -$164K ﹤0.01% 3742
2021
Q2
$190K Buy
28,764
+22,649
+370% +$150K ﹤0.01% 1970
2021
Q1
$45K Buy
6,115
+1,502
+33% +$11.1K ﹤0.01% 3230
2020
Q4
$27K Sell
4,613
-10,181
-69% -$59.6K ﹤0.01% 3677
2020
Q3
$88K Buy
14,794
+12,417
+522% +$73.9K ﹤0.01% 3245
2020
Q2
$12K Buy
2,377
+2,375
+118,750% +$12K ﹤0.01% 3954
2020
Q1
$0 Buy
+2
New ﹤0.01% 4436
2019
Q4
Sell
-1,471
Closed -$12K 4826
2019
Q3
$12K Sell
1,471
-1,042
-41% -$8.5K ﹤0.01% 2850
2019
Q2
$17K Buy
2,513
+1,863
+287% +$12.6K ﹤0.01% 2289
2019
Q1
$5K Sell
650
-438
-40% -$3.37K ﹤0.01% 3127
2018
Q4
$17K Sell
1,088
-515
-32% -$8.05K ﹤0.01% 2084
2018
Q3
$53K Buy
1,603
+403
+34% +$13.3K ﹤0.01% 1725
2018
Q2
$27K Buy
1,200
+1,179
+5,614% +$26.5K ﹤0.01% 2255
2018
Q1
$1K Sell
21
-3,417
-99% -$163K ﹤0.01% 3142
2017
Q4
$96K Buy
+3,438
New +$96K 0.01% 895
2017
Q3
Hold
0
4443
2017
Q2
Hold
0
3931
2017
Q1
Sell
-108
Closed -$1K 4325
2016
Q4
$1K Sell
108
-4,426
-98% -$41K ﹤0.01% 3713
2016
Q3
$40K Buy
4,534
+1,150
+34% +$10.1K ﹤0.01% 1262
2016
Q2
$33K Buy
3,384
+3,220
+1,963% +$31.4K ﹤0.01% 1872
2016
Q1
$1K Sell
164
-99
-38% -$604 ﹤0.01% 3895
2015
Q4
$3K Sell
263
-556
-68% -$6.34K ﹤0.01% 3577
2015
Q3
$10K Buy
819
+677
+477% +$8.27K ﹤0.01% 2338
2015
Q2
$2K Buy
+142
New +$2K ﹤0.01% 3844
2014
Q4
Sell
-10
Closed 5025
2014
Q3
$0 Buy
+10
New ﹤0.01% 5125
2014
Q2
Sell
-1,950
Closed -$29K 4944
2014
Q1
$29K Buy
+1,950
New +$29K ﹤0.01% 1547
2013
Q3
Sell
-400
Closed -$10K 4985
2013
Q2
$10K Buy
+400
New +$10K ﹤0.01% 2395